Hewlett Packard Enterprise Company (HPE)

Hewlett Packard Enterprise is trading at $50.25 after a 4.84% gain in the latest session, but the stock has pulled back sharply from its recent peak: it sits 31.69% below its 52-week high of $73.56 and 14.84% below its 50-day moving average. Analysts are still broadly positive, with 15 of 24 rating it buy or strong buy and none rating it sell, though Barclays cut its rating to Equal-Weight on October 14, 2026. For investors, the central question is whether the company's strong growth and earnings beats can carry the shares back above the averages that now sit overhead.

Hewlett Packard Enterprise has beaten EPS estimates in seven of its last eight reported quarters. The September 2, 2026 report showed adjusted EPS of $1.11 against an estimate of $0.94, a beat of 18.09%, and the shares rose 5.04% in the first session afterward. The June 1, 2026 report was an even larger beat, with EPS of $0.79 against $0.53 expected, and the stock jumped 19.47% in the next session. The one miss came with the March 9, 2026 report, when the stock fell 3.26% in the first session after that report. Overall, the market has rewarded most beats, though not every one, with 6 of the 8 reports followed by a higher share price.

At a trailing P/E of 24.39, the stock trades at a discount to peers, 30.5% below the sector median P/E of 35.1. Reported earnings per share over the last 12 months were $2.06, and the net profit margin was 6.4%. The return on equity of 10.94% is below the sector median of 13.4%, so the discount reflects profitability that trails the group, not only the growth rate.

Of 24 analysts with a current rating, 15 rate the stock buy or strong buy and 9 hold, with none at sell. Three months ago, 15 of 23 ratings were buys. On October 14, 2026, Barclays downgraded the stock to Equal-Weight from Overweight. Daiwa Capital upgraded it to Outperform from Neutral on October 2, 2026. On October 1, 2026, Citigroup and Morgan Stanley kept their buy-equivalent ratings, while Evercore ISI Group kept its In-Line rating and UBS kept its Neutral rating. The median 12-month target of $70.00 sits 39.3% above the price.

Insiders sold $86.4 million of stock over the last 18 months in 33 separate sales and made no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would.

Our base case for the coming months is that the stock stays range-bound between its 200-day average and its 20-day average while the market weighs two things at once. Revenue grew 33.70% in the latest quarter against the same quarter a year earlier, and analysts expect earnings per share for this fiscal year to rise 97.5%, to $3.83. If that growth shows up in coming reports, the shares could work back toward the 50-day average. The main risks are a slowdown in the growth rate, a further loss of analyst support, or continued selling pressure. Analysts' median 12-month target is $70.00, with a range of $62.00 to $92.00.

Support sits first at the 200-day simple moving average of $41.87, the nearest level below the price. A break under that average would bring the 52-week low of $19.84 into view, the second level below. Resistance sits first at the 20-day exponential moving average of $53.66, the nearest level above the price. The 50-day simple moving average of $59.01 comes next, and the 52-week high of $73.56 is the furthest level above the price.